
The world has not seen any data on Phase 1 or 2 clinical trials conducted by Moscow-based Gamaleya Research Institute, the Executive Chairperson of Bengaluru-headquartered Biocon Ltd said. "But it doesn't make them the world's first vaccine as several other vaccine programmes are even more advanced," she added.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3aoh8sU
via
IFTTT
0 comments:
Post a Comment